Cddsclassification 110323015224 Phpapp01

Controlled Drug Delivery System
Classification
Activation-modulated Drug Delivery System
In this group of controlled release drug delivery

system, the release of drug molecules from the
delivery system is activated by some physical,
chemical, or biochemical process and/or by
energy supplied externally.
The rate of drug release is then controlled by

regulating the process applied or energy input.
2 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

2
Classification : By Physical Means
Osmotic pressure
Activated
Activation-
Modulated
DDS
B R Nahata College of Pharmacy

22/01/2011 3 3
,Mandsaur M.P.
Osmotic Pressure Activated DDS
Delivery Orifice
Drug reservoir
( API + osmotic agent)
Semi-permeable
Membrane.
(cellulose esters)

4
For the drug delivery system containing a
solution formulation, the intrinsic rate of drug
release is defined by,
Q Pw Am
= ( s e )
t hm
For the drug delivery system containing a solid

formulation, the intrinsic rate of drug release is
defined by,
Q Pw Am
= ( s e ) Sd
t hm

5
Where,
Q/t - rate of drug release
Pw - permiability of semipermiable housing
Am -effective S.A. of semipermiable housing
hm - thickness of semipermiable housing
( s - e) Differential osmotic pressure b/w
DDS with osmotic pressure ps &
environmental osmotic pressure pe
Sd Aqueous solubility of drug contained in the
solid formulation.

6
Release is controlled at rate determined by,
Water permeability
Surface area of semi-permeable housing
Osmotic pressure gradient
Merits :
A high degree of in vivo- in vitro correlation (IVIVC)

is obtained in osmotic systems.
For oral osmotic systems, drug release is independent
of gastric pH and hydrodynamic conditions.

7
Alzet Osmotic Pump
22/01/2011 8 8
,Mandsaur M.P.
Osmotic pressure
Activated Hydrodynamic
Press. Activated
Activation-
Modulated
DDS

22/01/2011 9 9
,Mandsaur M.P.
Hydrodynamic Pressure - Activated DDS

10
Rate of drug release is defined by,
Q Pf Am
= ( qs - qe)
t hm
Where,
Pf = fluid permeability
Am = effective Surface area
hm = thickness of wall with anular opening
(qs - qe)= differential hydrodynamic pressure
between DDS and environment.

11
Release is controlled at rate determined by,
Fluid permeability
Pressure gradient
Surface area of wall with annular opening

12
Osmotic pressure
Press. Activated
Activation- Vapor
Modulated Pressure
DDS Activated

22/01/2011 13 13
,Mandsaur M.P.
Vapor Pressure Activated DDS

14
The rate of drug release is defined by,
Q = d4 (Ps -Pe)
t 40.74 ml
Where-
Q/t - rate of drug release
d - Inner diameter of cannula
l - length of cannula
(Ps -Pe) - the difference between the vapor
pressure in the vapor chamber &
pressure at the implantation site.
m - viscosity of the drug solution.

15
Rate controlled By :
Differential vapor pressure
Formulation viscosity
Size of the delivery cannula
Example,
An implantable infusion pump for constant
infusion of heparin in anticoagulant treatment,
morphine for patients suffering from the intense
pain of terminal cancer.
16 22/01/2011
B R Nahata College of Pharmacy ,Mandsaur M.P. 16
Osmotic pressure
Press. Activated
Activation- Vapor
Modulated Pressure
DDS Activated
Mechanically
Activated
22/01/2011 17 17
,Mandsaur M.P.
Mechanically Activated DDS
In this type, drug reservoir is in solution form
retained in a container equipped with
mechanically activated pumping system.
A measured dose of the drug formulation is

reproducible delivered in to a body cavity, for ex.
The nose, through the spray head upon manual
activation of the drug delivery pumping system.

18
Ex. Metered-dose Inhaler
the volume of solution

delivered is controllable, as
small as 10-100 l & is
independent of the force &
duration of the activation
applied as well as the solution
volume in the container.

19
Osmotic pressure
Press. Activated
Activation- Vapor
Modulated Pressure
DDS Activated
Mechanically
Magnetically Activated
Activated
22/01/2011 20 20
,Mandsaur M.P.
Magnetically Activated - DDS

21
In this type, drug reservoir is a dispersion of
peptide or protein powders in polymer matrix
from which macromolecular drug can be
delivered only at a relatively slow rate.
Device is fabricated by positioning a tiny magnet

ring in core of hemispherical drug dispersing
polymer matrix.
The external surface is coated with drug

impermeable polymer (ethylene vinyl acetate or
silicone elastomer) except one cavity at the centre
of the flat surface.
22
e.g. This delivery device used to deliver protein
drugs such as bovine serum albumin, at a low
basal rate, by a simple diffusion process under
non triggering condition.
As the magnet is activated to vibrate by an

external electromagnetic field, the drug
molecules are delivered at a much higher rate.

23
Osmotic pressure
Press. Activated
Activation- Vapor
Modulated Pressure
DDS Activated
Sonophoresis Mechanically
Activated Magnetically Activated
Activated
22/01/2011 24 24
,Mandsaur M.P.
Sonophoresis - Activated DDS
This type of system utilizes ultrasonic energy to
activate or trigger the delivery of drug from
polymeric drug delivery device.
System can be fabricated from nondegradable

polymer (ethylene vinyl acetate) or bioerodiable
polymer (poly[bis(p-carboxyphenoxy) alkane
anhydride].

25
26
Osmotic pressure
Press. Activated
Ionto- Activation- Vapor

phoresis Modulated Pressure
Activated DDS Activated
Activated
22/01/2011 B R Nahata College of Pharmacy ,Mandsaur M.P. 27 27
Iontophoresis - Activated DDS
Iontophorsis can be defined as the process in
which the flux or rate of absorption of ionic
solutes into or through skin is enhanced by
applying a voltage drop/electrical field across the
skin.
In addition, delivery rate can be controlled by the
intensity of applied electric current or Electro-
chemical potential gradient.

28
Iontophoresis facilitated skin permeation rate
of charged molecule (i) consist of 3 components
& is expressed by,
Jiisp = Jp + Je +Jc
Jp passive skin permeation flux.

Je electrical current driven permeation flux
Jc = convective flow driven skin permeation flux

29
30
Merits :
Non-invasive technique as a substitute for
chemical enhancers.
Frequency of dosage is reduced.
Provide predictable and extended duration of
action.
Demerits :
Excessive current density leads to pain.
The safe current density varies with electrode
size.
Mol. Wt. of 8000-12000 results in a uncertain
rate of delivery.
31
Osmotic pressure
Hydration Activated Hydrodynamic
Activated Press. Activated
Ionto- Activation- Vapor

phoresis Modulated Pressure
Activated DDS Activated
Activated
22/01/2011 32 32
,Mandsaur M.P.
Hydration - Activated DDS
Valrelease Tablets
33
Not only hydrophilic polymer but also the
lipophilic polymers, such as silicone elastomer,
can be modified to have swelling properties.
This is achieved by impregnating water-miscible

liquid such as glycerol and/or water soluble salt
such as, sodium chloride, in lipophilic polymer
matrix.

34
Classification By : Chemical Means
Activation-
Modulated
DDS
pH-Activated
DDS

35
pH-Activated DDS
This type of chemically activated system permits
targeting the delivery of drug only in the region
with selected pH range.
It fabricated by coating the drug-containing core

with a pH sensitive polymer combination.
For instances, a gastric fluid labile drug is

protected by encapsulating it inside a polymer
membrane that resist the degradative action of
gastric pH, such as combination of ethyl-
cellulose and hydroxymethylcellulose phthalate.
36
37
Activation- Ion-
Modulated Activated
DDS
DDS
pH-Activated
DDS

38
Ion-Activated DDS

39
An ionic or a charged drug can be delivered by
this method & this system are prepared by first
complexing an ionic drug with an ion-exchange
resin containing a suitable counter ion.
Ex. By forming a complex between a cationic

drug with a resin having a So3- group or between
an anionic drug with a resin having a N(CH3)3
group.
The granules of drug-resin complex are first

treated with an impregnating agent & then
coated with a water-insoluble but water-
permeable polymeric membrane.
40
This membrane serves as a rate-controlling barrier to
modulate the influx of ions as well as the release of
drug from the system.
Limitations :
The rate of release of the drug is directly proportional

to the concentration of ions at the site of action.

41
Hydrolysis- Activation- Ion-

Activated Modulated Activated
DDS DDS DDS
pH-Activated
DDS

42
Hydrolysis-Activated DDS
This type of system depends upon hydrolysis
process to activate the release of drug.
Drug reservoir is either encapsulated in
microcapsules or homogeneously dispersed in
microspheres or nano particles for injection.

43
It can also be fabricated as an implantable device.
All these systems prepared from bioerodible or
biodegradable polymers (polyanhydride, o-ester).
It is activated by hydrolysis-induced degradation
of polymer chain & is controlled by rate of
polymer degradation.
Ex. LHRH releasing biodegradable subdermal

implant, which is designed to deliver goserline, a
synthetic LHRH analog for once a month
treatment of prostate carcinoma.

44
Classification By : Biochemical Means
Enzyme - Activated Drug Delivery
System
This type of biochemical system depends on the

enzymatic process to activate the release of drug.
Drug reservoir is either physically entrapped in

microspheres or chemically bound to polymer chains
from biopolymers (albumins or polypeptides).

45
The release of drug is activated by enzymatic
hydrolysis of biopolymers (albumins or polypeptides)
by specific enzyme in target tissue.
Ex. Albumin microspheres release 5 fluorouracil
in a controlled manner by protease activated
biodegradation.

46
Feedback Regulated Drug Delivery System
In this group the release of drug molecules from
the delivery system is activated by a triggering
agent.
Rate of drug release is controlled by concen. of
triggering agent.
They are further classified as
A. Bioerosion -regulated drug delivery system
B. Bioresponsive drug delivery system
C. Self-regulating drug delivery system

47
A. Bioerosion - Regulated DDS

48
.Bioresponsive DDS
in this type, the drug reservoir is contained in a
device enclosed by bio-responsive membrane
whose drug permeability is controlled by conce.
of biochemical agent.
e.g. glucose-triggered insulin drug delivery

system.

49
50
C. Self-Regulating DDS
This type of system depends on a reversible &
competitive binding mechanism to activate and to
regulate the release of drug.
Drug reservoir is drug complex encapsulated
within a semi permeable polymeric membrane.
The release of drug from the delivery system is
activated by the membrane permeation of
biochemical agent from the tissue in which the
system is located

51
52
Effect Of System Parameters On CDDS
Polymer & Solution Solubility
Polymer & Solution Diffusivity
Thickness of polymer diffusion path & hydro-

dynamic layer
Partition Co-efficient
Surface Area
Loading Dose
22/01/2011
53 53
,Mandsaur M.P.
Polymer Solubility
For drug to be release, the drug molecules on the
outmost surface must dissociate from its crystal
lattice structure, partition or dissolve in
surrounding medium.
As the solubility of drug particles in rate

controlling membrane and polymer matrix plays
rate-controlling role in release from a polymeric
device. To release at an appropriate rate the drug
should have adequate polymer solubility.
Rate of drug release is directly proportional to

magnitude of polymer solubility.
Solution Solubility
Aqueous solubility varies from one drug to

another.
Difference in aqueous solubility is depend on the
difference in their chemical structure, types &
physicochemical nature of functional groups &
the variations in their stereo chemical
configurations.
Drug release increases with increase in Solution
solubility of drug.

Partition Coefficient
Partition co-efficient K of a drug for its
interfacial partitioning from the surface of a drug
delivery device towards an elution medium as
given :
K = Cs/Cp
Where,
Cs = conc. Of drug at the solution/polymer
interface
Cp = solubility of drug in the polymer phase.

Any variation in either Cs or Cp result in increase
or decrease in magnitude of K value.
Rate of drug release increase with increase in
partition coefficient

Polymer Diffusivity
The diffusion of small molecules in a polymer
structure is a energy activated process in which
the diffusant molecules move to a successive
series of equilibrium positions when a sufficient
amount of energy of activation for diffusion Ed,
has been acquired by the diffusant & its
surrounding polymer matrix.

Magnitude of polymer diffusivity is dependant
upon type of functional group and type of stereo
chemical position in diffusant molecule.
The bulkier the functional group attached to

polymer chain lower the polymer diffusivity.
Polymer diffusivity also depends on ,

1) Effect of cross linking (inverse relationship)
2) Effect of crystallinity (inverse relationship)
3) Effect of fillers

Solution Diffusivity
The diffusion of solute molecules in solution

medium is a result of the random motion of
molecules.
Under concentration gradient molecule diffuse
spontaneously from higher concentration to
lower concentration.
Diffusivity of solute molecule in aqueous
solution usually decreases as its concentration
increases

Thickness of hydrodynamic diffusion layer
Surface Area
Loading Dose.

Reference
Novel Drug Delivery System- Y.W.Chien.
published by Marcel Dekkar, inc., New York
Pg no. 17-36 & 57-111
Controlled And Novel Drug Delivery

N.K.Jain CBS Publishers & Distributors, New
Delhi.
www.pharmainfo.net

?

Cddsclassification 110323015224 Phpapp01

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Cddsclassification 110323015224 Phpapp01

Uploaded by

Copyright:

Available Formats

Controlled Drug Delivery System

In this group of controlled release drug delivery

The rate of drug release is then controlled by

2 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

B R Nahata College of Pharmacy

4 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

For the drug delivery system containing a solid

5 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

6 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

A high degree of in vivo- in vitro correlation (IVIVC)

7 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

B R Nahata College of Pharmacy

10 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

11 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

12 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

B R Nahata College of Pharmacy

14 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

15 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

A measured dose of the drug formulation is

18 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

the volume of solution

19 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

21 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

Device is fabricated by positioning a tiny magnet

The external surface is coated with drug

As the magnet is activated to vibrate by an

23 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

System can be fabricated from nondegradable

25 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

Ionto- Activation- Vapor

28 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

Jp passive skin permeation flux.

29 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

Ionto- Activation- Vapor

This is achieved by impregnating water-miscible

34 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

35 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

It fabricated by coating the drug-containing core

For instances, a gastric fluid labile drug is

38 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

39 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

Ex. By forming a complex between a cationic

The granules of drug-resin complex are first

The rate of release of the drug is directly proportional

41 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

Hydrolysis- Activation- Ion-

42 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

43 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

Ex. LHRH releasing biodegradable subdermal

44 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

This type of biochemical system depends on the

Drug reservoir is either physically entrapped in

45 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

46 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

They are further classified as

A. Bioerosion -regulated drug delivery system

B. Bioresponsive drug delivery system

C. Self-regulating drug delivery system

48 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

e.g. glucose-triggered insulin drug delivery

49 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

51 B R Nahata College of Pharmacy ,Mandsaur M.P. 22/01/2011

Polymer & Solution Diffusivity